Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells. | Blood Adv | 2023 | 36453632 | PubTator, text mining | PubMed |
| Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy. | Blood Cancer Discov | 2023 | 36413381 | PubTator, text mining | PubMed |
| Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR. | Cancer Immunol Res | 2023 | 36409926 | PubTator, text mining | PubMed |
| PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models. | Cell Oncol (Dordr) | 2023 | 36409438 | PubTator, text mining | PubMed |
| The emerging field of oncolytic virus-based cancer immunotherapy. | Trends Cancer | 2023 | 36402738 | PubTator, text mining | PubMed |
| Engineered T cell therapy for viral and non-viral epithelial cancers. | Cancer Cell | 2023 | 36400016 | PubTator, text mining | PubMed |
| Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy. | Blood Adv | 2023 | 36399526 | PubTator, text mining | PubMed |
| Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic. | Clin Cancer Res | 2023 | 36383184 | PubTator, text mining | PubMed |
| Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy. | Cancer Immunol Immunother | 2023 | 36355079 | PubTator, text mining | PubMed |
| Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss. | Annu Rev Med | 2023 | 36332638 | PubTator, text mining | PubMed |
| CD166-specific CAR-T cells potently target colorectal cancer cells. | Transl Oncol | 2023 | 36327697 | PubTator, text mining | PubMed |
| PTP4A2 promotes lysophagy by dephosphorylation of VCP/p97 at Tyr805. | Autophagy | 2023 | 36300783 | PubTator, text mining | PubMed |
| Emerging frontiers in immuno- and gene therapy for cancer. | Cytotherapy | 2023 | 36280438 | PubTator, text mining | PubMed |
| Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. | Cancer Discov | 2023 | 36259971 | PubTator, text mining | PubMed |
| Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing. | Cancer Immunol Res | 2023 | 36255409 | PubTator, text mining | PubMed |
| Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products. | Cytotherapy | 2023 | 36253252 | PubTator, text mining | PubMed |
| Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance. | Transplantation | 2023 | 36226849 | PubTator, text mining | PubMed |
| Genome-edited allogeneic donor "universal" chimeric antigen receptor T cells. | Blood | 2023 | 36223560 | PubTator, text mining | PubMed |
| Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy. | Heart Fail Rev | 2023 | 36221014 | PubTator, text mining | PubMed |
| Cellular immunotherapy for medulloblastoma. | Neuro Oncol | 2023 | 36219688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=44